Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06460233
Other study ID # KB/173/2020
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 21, 2021
Est. completion date June 15, 2026

Study information

Verified date June 2024
Source Medical University of Warsaw
Contact Grzegorz Styczynski, MD, PhD
Phone 48 502851288
Email grzegorz.styczynski@wum.edu.pl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to assess changes in blood pressure, cardiac function and selected laboratory measurements after bariatric surgery and to find most important factors associated with blood pressure reduction after weight loss. Description of the study Patients: consecutive patients with class III obesity (BMI ≥ 40kg/m2) or class II obesity (BMI 35-40kg/m2) with comorbidities, admitted for sleeve gastrectomy Methods: bedside and 24-hour blood pressure measurement, cardiac ultrasound and laboratory tests performed before surgery and at 1 week, 4 weeks, 6 months and 12 months after bariatric surgery


Description:

Pathogenesis of blood pressure reduction associated with weight loss is not established. We hypothesize that monitoring of blood pressure changes after weight loss, with concomitant evaluation of cardiac output and selected biochemical parameters related to blood pressure regulation may help in the understanding of weight loss-associated decrease in blood pressure. The study protocol include measurement of blood pressure (bedside and 24h blood pressure monitoring), assessment of the cardiac function and biochemistry 1-2 days before laparoscopic sleeve gastrectomy and at the time of routine surgical follow-up visits after surgery ie. one week, one month, six and twelve months. Blood pressure measurements will be performed using automatic oscillometric monitors (OnTrak , Spacelabs,USA). Cardiac evaluation will include an echocardiographic assessment of the systolic and diastolic left ventricular function as well as cardiac output measurement using Doppler method. Biochemistry measures, in addition to routine blood tests needed for surgical follow-up, will include fasting insulin, high sensivity C-reactive protein, cystatin C, and NT-proBNP.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 15, 2026
Est. primary completion date June 15, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - BMI =40kg/m2 or =35 kg/m2 with comorbidities Exclusion Criteria: - Lack of informed consent - Expected lack of compliance - Psychiatric illness - Previous bariatric surgery - Severe gastroesophageal reflux disease - Active neoplastic disease - Pregnancy - Chronic atrial fibrillation or other persistent arrhythmia

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Bariatric surgery - sleeve gastrectomy
Laparoscopic sleeve gastrectomy performed according to the current surgical standards

Locations

Country Name City State
Poland Central Warsaw Medical University Teaching Hospital Warsaw Mazowieckie

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Warsaw

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in the 24-hour blood pressure at one week after bariatric surgery (sleeve gastrectomy) Mean systolic and diastolic blood pressure in mmHg, measured using 24 hour ambulatory blood pressure monitor 1-2 days before and 7 to 10 days after surgery
Secondary Change from baseline in the 24-hour blood pressure at one month after bariatric surgery (sleeve gastrectomy) Mean systolic and diastolic blood pressure in mmHg, measured using 24 hour ambulatory blood pressure monitor 1-2 days before and 28 to 31 days after surgery
Secondary Change from baseline in the 24-hour blood pressure at six months after bariatric surgery (sleeve gastrectomy) Mean systolic and diastolic blood pressure in mmHg, measured using 24 hour ambulatory blood pressure monitor 1-2 days before and 5 to 7 months after surgery
Secondary Change from baseline in the 24-hour blood pressure at one year after bariatric surgery (sleeve gastrectomy) Mean systolic and diastolic blood pressure in mmHg measured using 24 hour ambulatory blood pressure monitor 1-2 days before and 11 to 13 months after surgery
Secondary Change from baseline in bedside blood pressure at one week after bariatric surgery Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study 1-2 days before and 7 to 10 days after surgery
Secondary Change from baseline in bedside blood pressure at one month after bariatric surgery Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study 1-2 days before and 28 to 31 days after surgery
Secondary Change from baseline in bedside blood pressure at six months after bariatric surgery Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study 1-2 days before and 5 to 7 months after surgery
Secondary Change from baseline in bedside blood pressure at one year after bariatric surgery Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study 1-2 days before and 11 to 13 months after surgery
Secondary Change from baseline in cardiac output at one week after bariatric surgery Echocardiographic measurement of cardiac output in liters per minute using Doppler method 1-2 days before and 7 to 10 days after surgery
Secondary Change from baseline in cardiac output at one month after bariatric surgery Echocardiographic measurement of cardiac output in liters per minute using Doppler method 1-2 days before and 28 to 31 days after surgery
Secondary Change from baseline in cardiac output at six months after bariatric surgery Echocardiographic measurement of cardiac output in liters per minute using Doppler method 1-2 days before and 5 to 7 months after surgery
Secondary Change from baseline in cardiac output at one year after bariatric surgery Echocardiographic measurement of cardiac output in liters per minute using Doppler method 1-2 days before and 11 to 13 months after surgery
Secondary Change from baseline in the left ventricular systolic function at one week after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method 1-2 days before and 7 to 10 days after bariatric surgery
Secondary Change from baseline in the left ventricular systolic function at one month after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method 1-2 days before and 28 to 31 days after bariatric surgery
Secondary Change from baseline in the left ventricular systolic function at six months after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method 1-2 days before and 5 to 7 months after bariatric surgery
Secondary Change from baseline in the left ventricular systolic function at one year after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method 1-2 days before and 11 to 13 months after bariatric surgery
Secondary Change from baseline in the left ventricular diastolic function at one week after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method 1-2 days before and 7 to 10 days after bariatric surgery
Secondary Change from baseline in the left ventricular diastolic function at one month after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method 1-2 days before and 28 to 31 days after bariatric surgery
Secondary Change from baseline in the left ventricular diastolic function at six months after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method 1-2 days before and 5 to 7 months after bariatric surgery
Secondary Change from baseline in the left ventricular diastolic function at one year after bariatric surgery Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method 1-2 days before and 11 to 13 months after bariatric surgery
Secondary Change from baseline in serum fasting insulin level at one week after bariatric surgery Laboratory measurement of serum fasting insulin level in µIU/ml 1-2 days before and 7 to 10 days after bariatric surgery
Secondary Change from baseline in serum fasting insulin level at one month after bariatric surgery Laboratory measurement of serum fasting insulin level in µIU/ml 1-2 days before and 28 to 31 days after bariatric surgery
Secondary Change from baseline in serum fasting insulin level at six months after bariatric surgery Laboratory measurement of serum fasting insulin level in µIU/ml 1-2 days before and 5 to 7 months after bariatric surgery
Secondary Change from baseline in serum fasting insulin level at one year after bariatric surgery Laboratory measurement of serum fasting insulin level in µIU/ml 1-2 days before and 11 to 13 months after bariatric surgery
Secondary Change from baseline in serum high- sensivity C-Reactive Protein level at one week after bariatric surgery Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l 1-2 days before and 7 to 10 days after bariatric surgery
Secondary Change from baseline in serum high- sensivity C-Reactive Protein level at one month after bariatric surgery Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l 1-2 days before and 28 to 31 days after bariatric surgery
Secondary Change from baseline in serum high- sensivity C-Reactive Protein level at six months after bariatric surgery Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l 1-2 days before and 5 to 7 months after bariatric surgery
Secondary Change from baseline in serum high- sensivity C-Reactive Protein level at one year after bariatric surgery Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l 1-2 days before and 11 to 13 months after bariatric surgery
Secondary Change from baseline in serum Cystatin C level at one week after bariatric surgery Laboratory measurement of serum Cystatin C level in mg/l 1-2 days before and 7 to 10 days after bariatric surgery
Secondary Change from baseline in serum Cystatin C level at one month after bariatric surgery Laboratory measurement of serum Cystatin C level in mg/l 1-2 days before and 28 to 31 days after bariatric surgery
Secondary Change from baseline in serum Cystatin C level at six months after bariatric surgery Laboratory measurement of serum Cystatin C level in mg/l 1-2 days before and 5 to 7 months after bariatric surgery
Secondary Change from baseline in serum Cystatin C level at one year after bariatric surgery Laboratory measurement of serum Cystatin C level in mg/l 1-2 days before and 11 to 13 months after bariatric surgery
Secondary Change from baseline in serum NT-proBNP level at one week after bariatric surgery Laboratory measurement of serum NT-proBNP level in pg/ml 1-2 days before and 7 to 10 days after bariatric surgery
Secondary Change from baseline in serum NT-proBNP level at one month after bariatric surgery Laboratory measurement of serum NT-proBNP level in pg/ml 1-2 days before and 28 to 31 days after bariatric surgery
Secondary Change from baseline in serum NT-proBNP level at six months after bariatric surgery Laboratory measurement of serum NT-proBNP level in pg/ml 1-2 days before and 5 to 7 months after bariatric surgery
Secondary Change from baseline in serum NT-proBNP level at one year after bariatric surgery Laboratory measurement of serum NT-proBNP level in pg/ml 1-2 days before and 11 to 13 months after bariatric surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2